News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

arGEN-X Uses Its Simple Antibody™ Platform To Identify Four "Hotspots" On MET As Targets For Its Therapeutic Antibody Program



4/7/2014 9:23:05 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BREDA, The Netherlands and GHENT, Belgium, April 7, 2014 /PRNewswire/ --

New findings to be presented at the American Association for Cancer Research annual meeting

arGEN-X, a clinical stage human therapeutic antibody company, will present data on how its SIMPLE Antibody™ platform has identified four 'hotspots' on the MET protein that are suitable for therapeutic antibody targeting. Encoded by the oncogene c-Met, MET signalling is involved in cancer proliferation and metastasis and is activated by hepatocyte growth factor (HGF) in multiple cancers.

Help employers find you! Check out all the jobs and post your resume.

Read at Yahoo Finance


comments powered by Disqus
arGEN-X
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES